366 related articles for article (PubMed ID: 24579331)
41. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
Tabár L; Dean PB; Chen TH; Yen AM; Chen SL; Fann JC; Chiu SY; Ku MM; Wu WY; Hsu CY; Chen YC; Beckmann K; Smith RA; Duffy SW
Cancer; 2019 Feb; 125(4):515-523. PubMed ID: 30411328
[TBL] [Abstract][Full Text] [Related]
42. Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
Etzioni R; Gulati R
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582245
[TBL] [Abstract][Full Text] [Related]
43. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
Demoor-Goldschmidt C; Drui D; Doutriaux I; Michel G; Auquier P; Dumas A; Berger C; Bernier V; Bohrer S; Bondiau PY; Filhon B; Fresneau B; Freycon C; Stefan D; Helfre S; Jackson A; Kerr C; Laprie A; Leseur J; Mahé MA; Oudot C; Pluchard C; Proust S; Sudour-Bonnange H; Vigneron C; Lassau N; Schlumberger M; Conter CF; de Vathaire F
BMC Cancer; 2017 May; 17(1):326. PubMed ID: 28499444
[TBL] [Abstract][Full Text] [Related]
44. Assessing mammography's benefits and harms.
Schmidt C
J Natl Cancer Inst; 2014 Apr; 106(4):dju103. PubMed ID: 24685934
[No Abstract] [Full Text] [Related]
45. Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance.
Basu P; Selmouni F; Belakhel L; Sauvaget C; Abousselham L; Lucas E; Muwonge R; Sankaranarayanan R; Khazraji YC
Int J Cancer; 2018 Dec; 143(12):3273-3280. PubMed ID: 30006933
[TBL] [Abstract][Full Text] [Related]
46. [Systematic screening for breast cancer in Rhone].
Courtial I; Brémond A; Victoria J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(1):9-16. PubMed ID: 8901296
[TBL] [Abstract][Full Text] [Related]
47. Breast cancer diagnosis by mammography in Kazakhstan - staging results of breast cancer with double reading.
Beysebayev E; Tulebayev K; Meymanalyev T
Asian Pac J Cancer Prev; 2015; 16(1):31-4. PubMed ID: 25640371
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer screening: a dividing controversy.
Khrouf S; Letaief Ksontini F; Ayadi M; Belhaj Ali Rais H; Mezlini A
Tunis Med; 2020 Jan; 98(1):22-34. PubMed ID: 32395774
[TBL] [Abstract][Full Text] [Related]
49. Why mammography screening has not lived up to expectations from the randomised trials.
Gøtzsche PC; Jørgensen KJ; Zahl PH; Mæhlen J
Cancer Causes Control; 2012 Jan; 23(1):15-21. PubMed ID: 22072221
[TBL] [Abstract][Full Text] [Related]
50. Association of Mammography Screening With a Reduction in Breast Cancer Mortality: A Modeling Study Using Population-Based Data From 2 French Departments.
Seigneurin A; Exbrayat C; Molinié F; Croisier L; Poncet F; Berquet K; Delafosse P; Colonna M
Am J Epidemiol; 2021 May; 190(5):827-835. PubMed ID: 33043362
[TBL] [Abstract][Full Text] [Related]
51. Cancer screening in France: third edition of the EDIFICE survey.
Viguier J; Morère JF; Touboul C; Coscas Y; Blay JY; Lhomel C; Pivot X; Eisinger F
Eur J Cancer Prev; 2015 Jun; 24 Suppl():S68-72. PubMed ID: 26016790
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Larrañaga N; Sarriugarte G; Mar J
BMC Cancer; 2015 Oct; 15():671. PubMed ID: 26459293
[TBL] [Abstract][Full Text] [Related]
53. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--yes.
Roder DM; Olver IN
Med J Aust; 2012 Jan; 196(1):16. PubMed ID: 22256917
[TBL] [Abstract][Full Text] [Related]
54. [Breast cancer screening in France: an overview in 2009].
Séradour B
Rev Prat; 2010 Feb; 60(2):191-9. PubMed ID: 20225555
[TBL] [Abstract][Full Text] [Related]
55. Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast.
Lee K; Kim H; Lee JH; Jeong H; Shin SA; Han T; Seo YL; Yoo Y; Nam SE; Park JH; Park YM
BMC Womens Health; 2016 Nov; 16(1):72. PubMed ID: 27863517
[TBL] [Abstract][Full Text] [Related]
56. Use of mammography as a breast cancer screening tool in six districts in France.
Lacour A; Mamelle N; Lafont S; Bazin B; Dubuc M; Exbrayat C; Trugeon A; Grosclaude P
Cancer Detect Prev; 1997; 21(5):460-70. PubMed ID: 9307849
[TBL] [Abstract][Full Text] [Related]
57. [Principles and first results of the European program of breast cancer screening in the Bas-Rhin].
Renaud R; Schaffer P; Gairard B; Dale G; Haehnel P; Kleitz C; Guldenfels C
Bull Acad Natl Med; 1991 Jan; 175(1):129-45; discussion 145-7. PubMed ID: 1863855
[TBL] [Abstract][Full Text] [Related]
58. Commentary on the Canadian National Breast Screening study.
Van Zee KJ; Hansen NM; Barrio AV; Connor CS; Danforth DN; Euhus DM; Kulkarni SA; McCready DR; McLaughlin S; Wilke LG
Ann Surg Oncol; 2014 Dec; 21(13):4397-8. PubMed ID: 24859935
[TBL] [Abstract][Full Text] [Related]
59. [Implementation of performance indicators in the Czech Breast Cancer Screening Programme - results of the regular monitoring].
Májek O; Bartoňková H; Daneš J; Skovajsová M; Dušek L
Klin Onkol; 2014; 27 Suppl 2():113-23. PubMed ID: 25494896
[TBL] [Abstract][Full Text] [Related]
60. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no.
Bell RJ; Burton RC
Med J Aust; 2012 Jan; 196(1):17. PubMed ID: 22256918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
